Panaxea™ CEO Dr. Daniel Weber, DSc PhD, has completed several research projects, and is the author of a number of peer-reviewed articles on oncology. Daniel has also completed research on triple negative breast cancer and Chinese Botanicals. Panaxea™ is currently engaged with studies on its AntiBioBotanical formula.